We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$63.1B
AUM Growth
+$3.79B
Cap. Flow
-$1.12B
Cap. Flow %
-1.77%
Top 10 Hldgs %
32.11%
Holding
999
New
156
Increased
303
Reduced
370
Closed
127

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$1.35B
2
INSM icon
Insmed
INSM
+$197M
3
HUBB icon
Hubbell
HUBB
+$191M
4
ARGX icon
argenx
ARGX
+$164M
5
SLNO
Soleno Therapeutics
SLNO
+$161M

Sector Composition

Rank Sector Weight
1 Technology 30.31%
2 Healthcare 13.97%
3 Financials 11.89%
4 Consumer Discretionary 9.55%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAM icon
776
EPAM Systems
EPAM
$4.86B
$3.12M ﹤0.01%
20,700
-41,200
-67% -$6.76M
GNRC icon
777
Generac Holdings
GNRC
$12.5B
$3.09M ﹤0.01%
18,458
-35,700
-66% -$6.25M
DNTH icon
778
Dianthus Therapeutics
DNTH
$6.15B
$3.03M ﹤0.01%
77,000
-108,000
-58% -$2.76M
WTTR icon
779
Select Water Solutions
WTTR
$2.57B
$2.99M ﹤0.01%
280,000
+250,000
+833% +$2.28M
NVGS icon
780
Navigator Holdings
NVGS
$1.29B
$2.97M ﹤0.01%
+191,578
New +$3.06M
ASIC
781
Ategrity Specialty Insurance
ASIC
$1.22B
$2.97M ﹤0.01%
150,000
-100,000
-40% -$2.1M
PGEN icon
782
Precigen
PGEN
$2.47B
$2.78M ﹤0.01%
846,000
-10,430,000
-92% -$29.4M
KPTI icon
783
Karyopharm Therapeutics
KPTI
$44.2M
$2.76M ﹤0.01%
421,322
SRDX
784
DELISTED
Surmodics
SRDX
$2.73M ﹤0.01%
+91,270
New +$3.05M
USPH icon
785
US Physical Therapy
USPH
$1.16B
$2.72M ﹤0.01%
+32,000
New +$2.56M
LYB icon
786
LyondellBasell Industries
LYB
$19.8B
$2.66M ﹤0.01%
54,300
-181,200
-77% -$10.2M
CCRN
787
DELISTED
Cross Country Healthcare
CCRN
$2.63M ﹤0.01%
+185,330
New +$2.45M
HOUS
788
DELISTED
Anywhere Real Estate
HOUS
$2.62M ﹤0.01%
+247,679
New +$1.46M
ALB icon
789
Albemarle
ALB
$14.8B
$2.61M ﹤0.01%
+32,179
New +$2.48M
BBWI icon
790
Bath & Body Works
BBWI
$4.06B
$2.58M ﹤0.01%
100,000
-25,000
-20% -$741K
PSA icon
791
Public Storage
PSA
$61.1B
$2.54M ﹤0.01%
8,792
-40,800
-82% -$11.7M
INVH icon
792
Invitation Homes
INVH
$18B
$2.51M ﹤0.01%
+85,735
New +$2.64M
OLN icon
793
Olin
OLN
$2.14B
$2.5M ﹤0.01%
+100,000
New +$2.22M
LFST icon
794
Lifestance Health
LFST
$4.07B
$2.48M ﹤0.01%
450,000
+175,000
+64% +$858K
CBIO
795
Crescent Biopharma
CBIO
$610M
$2.38M ﹤0.01%
200,005
+99,093
+98% +$1.31M
GKOS icon
796
Glaukos
GKOS
$10.1B
$2.33M ﹤0.01%
+28,582
New +$2.62M
AKAM icon
797
Akamai
AKAM
$17.2B
$2.31M ﹤0.01%
30,500
-3,400
-10% -$262K
KNSA icon
798
Kiniksa Pharmaceuticals
KNSA
$5.97B
$2.29M ﹤0.01%
+59,000
New +$1.92M
GAP
799
The Gap Inc
GAP
$7.39B
$2.21M ﹤0.01%
+103,200
New +$2.23M
BBY icon
800
Best Buy
BBY
$16.9B
$2.11M ﹤0.01%
27,900
-243,500
-90% -$17.5M

Similar funds

Adage Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Adage Capital Partners held 999 positions worth $63.1B, up 6.4% from $59.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q3 2025 filing shows 156 new, 303 increased, 370 reduced and 127 closed positions. Its largest new stake was Chevron: 3,284,841 shares worth $510M. The largest sale was Hess, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2025 buy was Chevron: 3,284,841 shares worth $510M.
  • Adage Capital Partners added most to Royalty Pharma in Q3 2025, an estimated $216M increase.
  • Adage Capital Partners's biggest Q3 2025 reduction was Insmed, cutting an estimated $197M.
  • Adage Capital Partners fully exited Hess in Q3 2025, selling an estimated $1.35B.
  • Adage Capital Partners's ten largest holdings make up 32% of its $63.1B portfolio in Q3 2025.
  • Adage Capital Partners opened 156 new positions and closed 127 in Q3 2025.
  • Adage Capital Partners's portfolio value rose 6.4% quarter-over-quarter to $63.1B.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.